🧭 MACRO SNAPSHOT

The macro setup got more complicated this week. CPI is hot enough that prediction markets are now seriously pricing the tail risk of a Fed hike in 2026 — not just delayed cuts. With Fed funds at 3.63%, the 2Y at 4.05% and 10Y at 4.45% (source: FRED), the curve is signaling the market doesn't fully believe in further easing. HY credit spreads at 278 bps remain benign, and VIX at 19.4 says no acute stress — but real GDP growth of 1.6% combined with sticky inflation is textbook late-cycle stagflation-lite. For long-duration growth equity, the valuation math has gotten harder, not easier. I'd be especially cautious adding to anything where the bull case requires multiple expansion from here.

The other macro shock is the SpaceX IPO — reportedly the largest in history, debuting +19% and triggering a violent rotation out of public space names ($RKLB -10% week, $AVAV -8%). This is a textbook narrative-driven dislocation: capital flowing to the new shiny IPO at the expense of incumbents whose fundamentals haven't changed. We've seen this movie before. Also notable: Paramount/Warner Bros Discovery cleared DOJ (consolidation accelerating in media), and the Anthropic "Fable" debacle is the biggest enterprise-AI trust story of the quarter — relevant for how CIOs are now thinking about LLM vendor risk.

₿ BITCOIN DAILY WRITE-UP

Price & Market Structure: BTC at $64,564, +1.06% on the day, +3.54% on the week, -19.73% on the month. We're roughly 49% off the November 2025 ATH around $126K and ~13-14 months past the April 2024 halving. Dominance at 56.7% — BTC is holding ground vs. alts in the drawdown, which is typical of bear/late-cycle behavior.

Structural Thesis: Bitcoin remains a long-duration, scarcity-anchored monetary asset whose investment case rests on three legs: (1) fixed supply meeting growing institutional demand via the ETF complex, (2) optionality on sovereign/pension adoption as a reserve asset, and (3) hedge against fiscal dominance and currency debasement. None of those legs requires a near-term price recovery to remain intact.

What Happened This Week: Standard Chartered called the cycle low at the $59K dip per Bitcoin Magazine — that's a call, not a confirmation. The Bitcoin Layer published a piece literally titled "Bitcoin's Never-Ending Bear Market" alongside a "$60K bottom?" post — sentiment in the dedicated BTC media is openly bearish/searching-for-bottom, which is itself a contrarian tell. No incremental ETF flow data point I'd act on; macro liquidity drag (TGA rebuild, delayed cuts) remains the dominant structural headwind.

Bull / Bear Scorecard

Bull:
- AIMCo's $160M Strategy position confirms sovereign/pension adoption continues at the margin — multi-year trend, one drawdown doesn't reverse it
- Standard Chartered (a real desk, not a Twitter account) calling cycle bottom suggests institutional bid is forming around the $59-65K zone
- BTC dominance holding 56.7% in a drawdown — capital concentrating in BTC over alts, structurally healthy

Bear:
- We are in the historical halving-cycle peak window (months 12-18 post-halving) and price is down 50% — this is a material deviation from 2013/2017/2021 patterns; the peak may already be in
- $900B Treasury cash rebuild draining liquidity from risk assets concurrent with delayed rate cuts — worst macro setup for BTC since 2022
- Historical post-peak drawdowns reached -77% to -84%; -50% may not be the bottom

Conviction Check: Action: HOLD | Conviction: 5/10. No change. The structural thesis is intact but the cycle math has clearly broken from prior halving patterns, and I'm not willing to add until either (a) ETF flows turn decisively positive or (b) macro liquidity reverses.

What to Watch:
- Spot BTC ETF flows — 30+ day sustained outflows would move me to reduce; return to net inflows is the cleanest re-entry signal
- TGA rebuild pace + any Fed liquidity accommodation
- Whether $59K holds as a higher low; a break below would invalidate the "cycle low is in" call

Community Pulse: Sentiment is openly bearish-to-confused. The Bitcoin Layer's "Never-Ending Bear Market" piece with Checkonchain and the "Is $60K the Bottom?" letter capture the mood — even dedicated BTC media is now openly debating whether the cycle is broken. Standard Chartered's bottom call is the lone institutional voice leaning bullish. Reddit was silent (Sunday). When dedicated bulls are asking "is this the bottom?" out loud, you're usually closer to one than the headlines suggest — but "closer" isn't "there."

🔬 TODAY'S DEEP DIVES

Only one deep dive on deck today — the PGNY rolling review. No new ideas screened.

PGNY — Progyny, Inc. — ROLLING REVIEW
Conviction: 5/10 | Status: WATCHLIST | Sector: Healthcare

WHAT THEY DO: Progyny is a benefits-management company that sells fertility, family-building, and women's health benefits to large self-insured employers. They sit between the employer (who pays them) and a curated network of fertility clinics — managing the benefit, the patient experience, and the clinical outcomes. Revenue is a mix of per-employee-per-month fees and treatment-cycle revenue.

WHY IT'S INTERESTING NOW: The stock has rallied +16.4% over the past month and +23.6% YoY to $26.63, with forward P/E compressing to 12.1x — meaning consensus earnings estimates have moved meaningfully higher. The question is whether durable growth is now being underwritten at a still-reasonable multiple, or whether the rally has fully closed the gap. The cluster of insider selling (CFO, GC, multiple directors in May) is a flag I can't dismiss.

BULL CASE:
- Disciplined capital allocation — $80M TTM buybacks (~40% of $200M FCF) executed in the $16-25 range, near multi-year lows. That's shareholder-aligned, not signaling-aligned
- Forward P/E of 12.1x for a category-defining benefits franchise in a structurally growing TAM (fertility benefits adoption among large employers is still <50% penetrated)
- No dividend, no aggressive M&A — reinvesting in adjacent product lines (menopause, maternity, women's health) which extends the runway without diluting focus

BEAR CASE:
- Insider selling cluster across CFO, GC, and multiple directors in May is a meaningful negative signal — especially right as the stock has rallied 23%
- D/E of 6.21 is high for a healthcare benefits franchise — leverage limits flexibility if employer churn accelerates in a recession
- Customer concentration risk: large self-insured employers can in-source or switch carriers; the business model is sticky but not moat-grade

KEY METRICS: Forward P/E 12.1x, TTM FCF $200M, $80M buybacks executed near lows, +23.6% YoY price. Differentiator vs. peers: only pure-play public fertility-benefits manager with category leadership.

BOTTOM LINE: Stays on the watchlist at 5/10 — the valuation isn't demanding, but the insider selling cluster + leverage profile keeps me from upgrading until I see the next earnings print confirm the higher consensus EPS trajectory.

📋 TARGET LIST STATUS

No conviction changes today. No names dropped today. The SpaceX IPO is going to force a re-think on $RKLB and $AVAV — both are now down 20%+ on the month for reasons that are narrative, not fundamental. If RKLB or AVAV fundamentals come through in the next print, they could be conviction-upgrade candidates on this dislocation.

💼 YOUR PORTFOLIO

• $AAPL | HOLD | 6/10 — WWDC reveal underwhelmed the market; AI features shipped but didn't surprise. Holding through the noise — the platform thesis is intact.
• $AVAV | HOLD | 5/10 — Down ~10% since last check on SpaceX shakeout + new securities fraud overhang. Litigation is a real flag; not adding.
• $AVGO | BUY MORE | 9/10 — Down 8% on the chip pullback; thesis intact (custom silicon + VMware). Highest-conviction add on the book.
• $BABA | STRONG HOLD | 8/10 — Now -41.5% from 52W high. China sentiment ugly but valuation is asymmetric; staying.
• $FSLR | HOLD | 7/10 — Big $3.5B project financing news is incrementally positive but the -14% week reflects rate-sensitivity. Holding.
• $GOOGL | STRONG HOLD | 9/10 (note: portfolio shows 5/10 but analysis text says 9/10; treating analysis as authoritative) — Capex concerns weighing, but search + cloud thesis intact.
• $ISRG | BUY MORE | 8/10 — Bouncing along 52W lows; long-term robotic surgery thesis untouched by recent weakness. Best entry point in a year.
• $MKL | HOLD | 7/10 — Modest recovery off the lows; waiting for fundamental confirmation.
• $MP | HOLD | 7/10 — Down to $57; rare earth thesis intact but the news flow has cooled.
• $SYM | HOLD | 6/10 — Down ~10% since last review; warehouse automation thesis intact, sentiment is the issue.
• $TSLA | HOLD | 5/10 — Robotaxi rollout in Austin progressing but execution risk remains high. Holding, not adding.
• $UNH | STRONG HOLD | 7/10 — Within 2.5% of 52W high; JPM and Mizuho both turned positive. Thesis playing out.

⚠️ WATCH LIST

• $RKLB — Down 22.75% on the month on SpaceX-IPO contagion, not fundamentals. If next quarterly print shows continued Neutron progress + Electron cadence, this is a conviction upgrade candidate. Trigger: revenue beat + Neutron timeline confirmation.
• $AVAV — Securities class action is a real overhang. Need to see the complaint and assess whether it's frivolous or material. Downgrade trigger: any admission in 8-K or 10-Q disclosures.
• $UUUU — Down 22.87% on the month with no fundamental deterioration. Watching for catalyst (uranium spot price, production guidance confirmation). Could move to RECOMMEND on a 15-20% rebound + production confirmation.
• $NOW — Down 10.5% week but +12.87% month — high volatility around AI narratives. Need cleaner data on Now Assist monetization to upgrade.

🔁 RE-REVIEW QUEUE

Eight names hit the re-review window today. The macro setup has shifted meaningfully since most of these were dropped (inflation reaccelerated, SpaceX IPO, AI-vendor trust crisis), so several deserve a fresh look:

• $CEG | Was 6/10 | Dropped 2026-05-13 — Dropped on the 50-name cutoff. AI power-demand thesis has only strengthened (Vistra news, GEV 800VDC). Worth a fresh dive.
• $DDOG | Was 6/10 | Dropped 2026-05-07 — Dropped on conviction threshold. Anthropic trust crisis = enterprise observability of AI workloads matters more, not less.
• $TTD | Was 6/10 | Dropped 2026-05-07 — Ad-tech volatility around AI-driven measurement. Worth revisiting if next print confirms CTV momentum.
• $BWXT | Was 6/10 | Dropped 2026-05-13 — Small modular reactor / nuclear infrastructure thesis stronger now given power-demand narrative.
• $NET | Was 6/10 | Dropped 2026-05-07 — Cybersecurity in spotlight per news flow. Cloudflare's edge story still differentiated.
• $KTOS | Was 6/10 | Dropped 2026-05-13 — Autonomous weapons narrative ("smart money betting billions") is exactly the KTOS pitch. Worth a fresh look.
• $CRWD | Was 6/10 | Dropped 2026-05-08 — Cyber tailwinds re-emerging; PANW and FTNT both up sharply on the month.
• $NTRA | Was 6/10 | Dropped 2026-05-09 — No new catalyst flagged; lowest priority of the queue.

To run a fresh dive on any of these, ask Meridian in the chat.